Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0002274,GO:0002274,myeloid leukocyte activation,8/36,232/18800,1.07101723178987e-08,1.65257958865177e-05,8.26374348317868e-06,CHGA/CSF1/HAVCR2/IFNGR1/LGALS9/LTBR/TGFBR2/VSIG4,8
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,7/36,233/18800,2.5230806309852e-07,0.0001946556706805,9.73377948690606e-05,CSF1/HAVCR2/LGALS9/TGFBR2/TNFRSF14/TNFRSF1B/VSIG4,7
GO:0042129,GO:0042129,regulation of T cell proliferation,6/36,174/18800,8.91982701902021e-07,0.0003440823272587,0.0001720587685511,HAVCR2/LGALS9/TGFBR2/TNFRSF14/TNFRSF1B/VSIG4,6
GO:0032102,GO:0032102,negative regulation of response to external stimulus,8/36,429/18800,1.18991578621506e-06,0.0003546678919029,0.000177352092482,CCN3/HAVCR2/LGALS9/NBL1/THBD/TNFRSF1A/TNFRSF1B/VSIG4,8
GO:0032943,GO:0032943,mononuclear cell proliferation,7/36,300/18800,1.37913632625906e-06,0.0003546678919029,0.000177352092482,CSF1/HAVCR2/LGALS9/TGFBR2/TNFRSF14/TNFRSF1B/VSIG4,7
GO:0042098,GO:0042098,T cell proliferation,6/36,204/18800,2.25197470986915e-06,0.0004429573413293,0.0002215013345119,HAVCR2/LGALS9/TGFBR2/TNFRSF14/TNFRSF1B/VSIG4,6
GO:0071675,GO:0071675,regulation of mononuclear cell migration,5/36,116/18800,2.65341802670182e-06,0.0004429573413293,0.0002215013345119,CCN3/CSF1/LGALS9/NBL1/TNFRSF14,5
GO:0048013,GO:0048013,ephrin receptor signaling pathway,4/36,52/18800,2.8707539943573e-06,0.0004429573413293,0.0002215013345119,EFNA1/EFNA4/EPHA2/EPHB4,4
GO:0042742,GO:0042742,defense response to bacterium,7/36,364/18800,4.95481495602161e-06,0.0006371066230951,0.0003185859090143,CHGA/EPHA2/HAVCR2/LCN2/TNFRSF14/TNFRSF1A/WFDC2,7
GO:0050900,GO:0050900,leukocyte migration,7/36,384/18800,7.03257879463141e-06,0.0007613263121281,0.000380702109213,B4GALT1/CCN3/CHGA/CSF1/LGALS9/NBL1/TNFRSF14,7
GO:0003170,GO:0003170,heart valve development,4/36,65/18800,7.05330418174545e-06,0.0007613263121281,0.000380702109213,EFNA1/TGFBR2/TNFRSF1A/TNFRSF1B,4
GO:1903531,GO:1903531,negative regulation of secretion by cell,5/36,143/18800,7.4010983032552e-06,0.0007613263121281,0.000380702109213,CCN3/CHGA/LGALS9/TNFRSF1A/TNFRSF1B,5
GO:0002519,GO:0002519,natural killer cell tolerance induction,2/36,3/18800,1.06825568706833e-05,0.0008764961837329,0.0004382929376649,HAVCR2/LGALS9,2
GO:0014028,GO:0014028,notochord formation,2/36,3/18800,1.06825568706833e-05,0.0008764961837329,0.0004382929376649,EFNA1/EPHA2,2
GO:0031348,GO:0031348,negative regulation of defense response,6/36,268/18800,1.07928888470027e-05,0.0008764961837329,0.0004382929376649,CCN3/HAVCR2/LGALS9/TNFRSF1A/TNFRSF1B/VSIG4,6
GO:0002683,GO:0002683,negative regulation of immune system process,7/36,425/18800,1.36000806380876e-05,0.0010492462212284,0.000524676795143,CCN3/CD59/HAVCR2/LGALS9/NBL1/TNFRSF14/VSIG4,7
GO:0050777,GO:0050777,negative regulation of immune response,5/36,179/18800,2.19576540181121e-05,0.0013012085552119,0.0006506708537506,CD59/HAVCR2/LGALS9/TNFRSF14/VSIG4,5
GO:0060326,GO:0060326,cell chemotaxis,6/36,315/18800,2.6902159768005e-05,0.0014313804317942,0.0007157634522667,CCN3/CHGA/CSF1/EPHA2/LGALS9/NBL1,6
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,2/36,5/18800,3.55227153041971e-05,0.0017059207716536,0.0008530476690126,TNFRSF1A/TNFRSF1B,2
GO:0008630,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,4/36,101/18800,4.05008006947652e-05,0.00183802163153,0.0009191048578719,EPHA2/SHISA5/TNFRSF1A/TNFRSF1B,4
GO:0050863,GO:0050863,regulation of T cell activation,6/36,342/18800,4.26179603698237e-05,0.0018788432243039,0.0009395177428896,HAVCR2/LGALS9/TGFBR2/TNFRSF14/TNFRSF1B/VSIG4,6
GO:0044706,GO:0044706,multi-multicellular organism process,5/36,213/18800,5.04457639862963e-05,0.0019345787022405,0.0009673883335554,B4GALT1/HAVCR2/LGALS9/TGFBR2/THBD,5
GO:2001188,GO:2001188,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/36,6/18800,5.3219844325889e-05,0.0019345787022405,0.0009673883335554,HAVCR2/LGALS9,2
GO:0050866,GO:0050866,negative regulation of cell activation,5/36,216/18800,5.39124330501256e-05,0.0019345787022405,0.0009673883335554,HAVCR2/LGALS9/THBD/TNFRSF14/VSIG4,5
GO:0018108,GO:0018108,peptidyl-tyrosine phosphorylation,6/36,373/18800,6.89844124278547e-05,0.0022175614245037,0.0011088941734565,EFNA1/EPHA2/EPHB4/GFRA1/TNFRSF14/TNFRSF1A,6
GO:0090027,GO:0090027,negative regulation of monocyte chemotaxis,2/36,7/18800,7.44179803552778e-05,0.0022965388737638,0.0011483869389561,CCN3/NBL1,2
GO:0060443,GO:0060443,mammary gland morphogenesis,3/36,44/18800,8.09142919399504e-05,0.0024328268528795,0.0012165379016684,CSF1/EPHA2/TGFBR2,3
GO:0097028,GO:0097028,dendritic cell differentiation,3/36,47/18800,9.86755862042442e-05,0.0027306800494675,0.0013654797395775,LGALS9/LTBR/TGFBR2,3
GO:0003007,GO:0003007,heart morphogenesis,5/36,254/18800,0.0001158548904566,0.0031362122100811,0.0015682665688777,DLL1/EFNA1/EPHB4/FOLR1/TGFBR2,5
GO:0009855,GO:0009855,determination of bilateral symmetry,4/36,138/18800,0.0001364231115169,0.0036293251908741,0.0018148482893275,DLL1/FOLR1/NBL1/TGFBR2,4
GO:0090092,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,5/36,267/18800,0.0001463425747464,0.0037575006743162,0.0018789425891283,CCN3/FOLR1/GDF15/NBL1/TGFBR2,5
GO:0002291,GO:0002291,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/36,10/18800,0.0001588913227088,0.0037575006743162,0.0018789425891283,HAVCR2/LGALS9,2
GO:1903038,GO:1903038,negative regulation of leukocyte cell-cell adhesion,4/36,144/18800,0.0001607226471191,0.0037575006743162,0.0018789425891283,HAVCR2/LGALS9/TNFRSF14/VSIG4,4
GO:0046718,GO:0046718,viral entry into host cell,4/36,146/18800,0.0001694763273607,0.0039030145241438,0.0019517069592369,EPHA2/LGALS9/NECTIN4/TNFRSF14,4
GO:0045785,GO:0045785,positive regulation of cell adhesion,6/36,446/18800,0.0001835302711027,0.0041645177692874,0.0020824719615838,CSF1/HAVCR2/LGALS9/PLAUR/TGFBR2/TNFRSF14,6
GO:0001947,GO:0001947,heart looping,3/36,64/18800,0.0002479417186138,0.0047821758977651,0.0023913326282101,DLL1/FOLR1/TGFBR2,3
GO:0001667,GO:0001667,ameboidal-type cell migration,6/36,480/18800,0.0002727900871192,0.0050407889801972,0.0025206524013266,CCN3/EFNA1/EPHA2/EPHB4/FOLR1/TGFBR2,6
GO:1903054,GO:1903054,negative regulation of extracellular matrix organization,2/36,13/18800,0.0002744175465564,0.0050407889801972,0.0025206524013266,TNFRSF1A/TNFRSF1B,2
GO:0061371,GO:0061371,determination of heart left/right asymmetry,3/36,68/18800,0.0002966763102399,0.0053855476082384,0.0026930493548717,DLL1/FOLR1/TGFBR2,3
GO:0043410,GO:0043410,positive regulation of MAPK cascade,6/36,491/18800,0.0003080260606868,0.0054936909239229,0.0027471265458508,EFNA1/GDF15/HAVCR2/IGFBP4/LGALS9/LTBR,6
GO:0009988,GO:0009988,cell-cell recognition,3/36,69/18800,0.0003097544461317,0.0054936909239229,0.0027471265458508,B4GALT1/FOLR1/HAVCR2,3
GO:0070278,GO:0070278,extracellular matrix constituent secretion,2/36,14/18800,0.0003197682350115,0.0056033307391454,0.0028019520631671,TNFRSF1A/TNFRSF1B,2
GO:0045824,GO:0045824,negative regulation of innate immune response,3/36,73/18800,0.0003657773603828,0.0062021370007772,0.0031013858318175,HAVCR2/LGALS9/VSIG4,3
GO:0060562,GO:0060562,epithelial tube morphogenesis,5/36,328/18800,0.0003791068151098,0.006358280605593,0.00317946562329,CSF1/DLL1/EPHA2/FOLR1/TGFBR2,5
GO:0001906,GO:0001906,cell killing,4/36,185/18800,0.0004179954660797,0.0068323636907072,0.0034165314222385,CD59/CHGA/HAVCR2/LGALS9,4
GO:0007565,GO:0007565,female pregnancy,4/36,185/18800,0.0004179954660797,0.0068323636907072,0.0034165314222385,HAVCR2/LGALS9/TGFBR2/THBD,4
GO:2001267,GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,2/36,17/18800,0.0004761712238242,0.0073473219836083,0.0036740369164545,LGALS9/PLAUR,2
GO:0035050,GO:0035050,embryonic heart tube development,3/36,84/18800,0.0005523344800102,0.0081947317563062,0.0040977851604001,DLL1/FOLR1/TGFBR2,3
GO:0090132,GO:0090132,epithelium migration,5/36,361/18800,0.0005866978997055,0.008438313748716,0.0042195886194418,CCN3/EFNA1/EPHA2/EPHB4/TGFBR2,5
GO:0033627,GO:0033627,cell adhesion mediated by integrin,3/36,86/18800,0.0005916809001616,0.008438313748716,0.0042195886194418,CCN3/EFNA1/EPHA2,3
GO:0002064,GO:0002064,epithelial cell development,4/36,203/18800,0.0005930740394489,0.008438313748716,0.0042195886194418,B4GALT1/DLL1/EPHA2/TNFRSF1A,4
GO:0001818,GO:0001818,negative regulation of cytokine production,5/36,363/18800,0.0006015648168235,0.008438313748716,0.0042195886194418,DLL1/EPHA2/HAVCR2/LGALS9/VSIG4,5
GO:0044342,GO:0044342,type B pancreatic cell proliferation,2/36,20/18800,0.0006628399525282,0.0086674749724673,0.0043341809563178,CCN3/IGFBP4,2
GO:1902004,GO:1902004,positive regulation of amyloid-beta formation,2/36,20/18800,0.0006628399525282,0.0086674749724673,0.0043341809563178,EFNA1/IFNGR1,2
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,5/36,381/18800,0.0007484787986434,0.0093894535472104,0.0046952071836171,HAVCR2/LGALS9/TGFBR2/TNFRSF14/VSIG4,5
GO:0032602,GO:0032602,chemokine production,3/36,98/18800,0.0008656095849711,0.0103586127037537,0.0051798363487747,EPHA2/HAVCR2/LGALS9,3
GO:0050920,GO:0050920,regulation of chemotaxis,4/36,225/18800,0.000871251376362,0.0103586127037537,0.0051798363487747,CCN3/CSF1/LGALS9/NBL1,4
GO:0031341,GO:0031341,regulation of cell killing,3/36,100/18800,0.0009178570161401,0.0107291922416986,0.0053651450783948,CD59/HAVCR2/LGALS9,3
GO:0032760,GO:0032760,positive regulation of tumor necrosis factor production,3/36,103/18800,0.0009999168013624,0.0112618366751992,0.0056314945478193,HAVCR2/IFNGR1/LGALS9,3
GO:0007411,GO:0007411,axon guidance,4/36,234/18800,0.0010079017841223,0.0112695105282666,0.0056353318669846,EFNA1/EFNA4/EPHA2/EPHB4,4
GO:0001911,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,2/36,25/18800,0.0010403087180015,0.0113041996611009,0.0056526782082661,HAVCR2/LGALS9,2
GO:0033209,GO:0033209,tumor necrosis factor-mediated signaling pathway,3/36,107/18800,0.0011163650006763,0.0117356166036365,0.0058684087529184,TNFRSF14/TNFRSF1A/TNFRSF1B,3
GO:0060561,GO:0060561,apoptotic process involved in morphogenesis,2/36,26/18800,0.0011256456625652,0.0117356166036365,0.0058684087529184,TNFRSF1A/TNFRSF1B,2
GO:0042060,GO:0042060,wound healing,5/36,429/18800,0.0012718069911997,0.0127596766651226,0.0063804911795442,B4GALT1/CD59/PLAUR/TGFBR2/THBD,5
GO:0090257,GO:0090257,regulation of muscle system process,4/36,250/18800,0.0012870609390974,0.0127596766651226,0.0063804911795442,CHGA/DSC2/TNFRSF1A/TNFRSF1B,4
GO:0002832,GO:0002832,negative regulation of response to biotic stimulus,3/36,113/18800,0.0013065644284441,0.0127596766651226,0.0063804911795442,HAVCR2/LGALS9/VSIG4,3
GO:0032103,GO:0032103,positive regulation of response to external stimulus,5/36,442/18800,0.0014513492765515,0.0139964495857439,0.0069989409191597,CSF1/HAVCR2/LGALS9/THBD/TNFRSF1A,5
GO:0003147,GO:0003147,neural crest cell migration involved in heart formation,1/36,1/18800,0.0019148936170211,0.0157110898967199,0.0078563488039674,FOLR1,1
GO:0021688,GO:0021688,cerebellar molecular layer formation,1/36,1/18800,0.0019148936170211,0.0157110898967199,0.0078563488039674,DLL1,1
GO:0060853,GO:0060853,Notch signaling pathway involved in arterial endothelial cell fate commitment,1/36,1/18800,0.0019148936170211,0.0157110898967199,0.0078563488039674,DLL1,1
GO:0070238,GO:0070238,activated T cell autonomous cell death,1/36,1/18800,0.0019148936170211,0.0157110898967199,0.0078563488039674,LGALS9,1
GO:0070239,GO:0070239,regulation of activated T cell autonomous cell death,1/36,1/18800,0.0019148936170211,0.0157110898967199,0.0078563488039674,LGALS9,1
GO:0070241,GO:0070241,positive regulation of activated T cell autonomous cell death,1/36,1/18800,0.0019148936170211,0.0157110898967199,0.0078563488039674,LGALS9,1
GO:0086030,GO:0086030,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,1/36,1/18800,0.0019148936170211,0.0157110898967199,0.0078563488039674,CHGA,1
GO:1902228,GO:1902228,positive regulation of macrophage colony-stimulating factor signaling pathway,1/36,1/18800,0.0019148936170211,0.0157110898967199,0.0078563488039674,CSF1,1
GO:1905317,GO:1905317,inferior endocardial cushion morphogenesis,1/36,1/18800,0.0019148936170211,0.0157110898967199,0.0078563488039674,TGFBR2,1
GO:0046676,GO:0046676,negative regulation of insulin secretion,2/36,34/18800,0.0019244303243551,0.0157110898967199,0.0078563488039674,CCN3/CHGA,2
GO:0070232,GO:0070232,regulation of T cell apoptotic process,2/36,34/18800,0.0019244303243551,0.0157110898967199,0.0078563488039674,EFNA1/LGALS9,2
GO:0033674,GO:0033674,positive regulation of kinase activity,5/36,476/18800,0.0020094200010945,0.0163186055878366,0.0081601377329769,CSF1/EFNA1/EPHA2/EPHB4/TGFBR2,5
GO:0010614,GO:0010614,negative regulation of cardiac muscle hypertrophy,2/36,35/18800,0.0020386101678416,0.0164689816176945,0.0082353334418733,TNFRSF1A/TNFRSF1B,2
GO:0042063,GO:0042063,gliogenesis,4/36,291/18800,0.0022424757044668,0.0173876382512179,0.0086947087615668,CSF1/DLL1/IFNGR1/TNFRSF1B,4
GO:0051154,GO:0051154,negative regulation of striated muscle cell differentiation,2/36,39/18800,0.0025266645103352,0.0189254531041129,0.0094636948700854,CCN3/DLL1,2
GO:0002792,GO:0002792,negative regulation of peptide secretion,2/36,40/18800,0.0026564531524466,0.01971629123693,0.0098591543996109,CCN3/CHGA,2
GO:0071496,GO:0071496,cellular response to external stimulus,4/36,309/18800,0.0027855621368105,0.0204949228672144,0.0102485100533261,DSC2/FOLR1/LTBR/TNFRSF1A,4
GO:1902107,GO:1902107,positive regulation of leukocyte differentiation,3/36,157/18800,0.0033331069706202,0.0232435459602068,0.0116229622327193,CSF1/LGALS9/TGFBR2,3
GO:1903708,GO:1903708,positive regulation of hemopoiesis,3/36,157/18800,0.0033331069706202,0.0232435459602068,0.0116229622327193,CSF1/LGALS9/TGFBR2,3
GO:0046631,GO:0046631,alpha-beta T cell activation,3/36,158/18800,0.0033931784987441,0.0232435459602068,0.0116229622327193,LGALS9/TGFBR2/TNFRSF14,3
GO:0048638,GO:0048638,regulation of developmental growth,4/36,329/18800,0.0034882129965426,0.0232435459602068,0.0116229622327193,CSF1/DLL1/GDF15/TGFBR2,4
GO:0032496,GO:0032496,response to lipopolysaccharide,4/36,333/18800,0.0036419800798568,0.0232435459602068,0.0116229622327193,HAVCR2/LGALS9/THBD/TNFRSF1B,4
GO:0007568,GO:0007568,aging,3/36,163/18800,0.0037035195152159,0.0232435459602068,0.0116229622327193,GFRA1/TGFBR2/TNFRSF1B,3
GO:0033628,GO:0033628,regulation of cell adhesion mediated by integrin,2/36,48/18800,0.003804909145153,0.0232435459602068,0.0116229622327193,EFNA1/EPHA2,2
GO:0002298,GO:0002298,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response",1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,LGALS9,1
GO:0005988,GO:0005988,lactose metabolic process,1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,B4GALT1,1
GO:0005989,GO:0005989,lactose biosynthetic process,1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,B4GALT1,1
GO:0021693,GO:0021693,cerebellar Purkinje cell layer structural organization,1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,DLL1,1
GO:0032832,GO:0032832,"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response",1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,LGALS9,1
GO:0032834,GO:0032834,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response",1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,LGALS9,1
GO:0042488,GO:0042488,positive regulation of odontogenesis of dentin-containing tooth,1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,CSF1,1
GO:0060434,GO:0060434,bronchus morphogenesis,1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,TGFBR2,1
GO:0060974,GO:0060974,cell migration involved in heart formation,1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,FOLR1,1
GO:0071231,GO:0071231,cellular response to folic acid,1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,FOLR1,1
GO:0097102,GO:0097102,endothelial tip cell fate specification,1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,DLL1,1
GO:1904057,GO:1904057,negative regulation of sensory perception of pain,1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,CCN3,1
GO:2000707,GO:2000707,positive regulation of dense core granule biogenesis,1/36,2/18800,0.0038262220828856,0.0232435459602068,0.0116229622327193,CHGA,1
GO:0035036,GO:0035036,sperm-egg recognition,2/36,49/18800,0.0039620617089461,0.0238807078785308,0.0119415757921773,B4GALT1/FOLR1,2
GO:0043303,GO:0043303,mast cell degranulation,2/36,50/18800,0.0041221973931421,0.0242358762110255,0.0121191781305602,CHGA/LGALS9,2
GO:0070231,GO:0070231,T cell apoptotic process,2/36,50/18800,0.0041221973931421,0.0242358762110255,0.0121191781305602,EFNA1/LGALS9,2
GO:0045765,GO:0045765,regulation of angiogenesis,4/36,345/18800,0.0041309367747891,0.0242358762110255,0.0121191781305602,DLL1/EFNA1/EPHA2/TGFBR2,4
GO:0045861,GO:0045861,negative regulation of proteolysis,4/36,350/18800,0.0043472118203029,0.0254081357527553,0.0127053678799124,COL6A3/EFNA1/PLAUR/WFDC2,4
GO:0002448,GO:0002448,mast cell mediated immunity,2/36,52/18800,0.0044513727503828,0.0256286125143311,0.0128156175413614,CHGA/LGALS9,2
GO:0034205,GO:0034205,amyloid-beta formation,2/36,56/18800,0.0051450235142239,0.027822482447214,0.0139126647568358,EFNA1/IFNGR1,2
GO:0051251,GO:0051251,positive regulation of lymphocyte activation,4/36,371/18800,0.0053395528886201,0.027822482447214,0.0139126647568358,HAVCR2/LGALS9/TGFBR2/TNFRSF14,4
GO:0002040,GO:0002040,sprouting angiogenesis,3/36,186/18800,0.0053522677166062,0.027822482447214,0.0139126647568358,DLL1/EPHA2/EPHB4,3
GO:0031099,GO:0031099,regeneration,3/36,188/18800,0.00551332550222,0.027822482447214,0.0139126647568358,CCN3/FOLR1/TGFBR2,3
GO:0002652,GO:0002652,regulation of tolerance induction dependent upon immune response,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,HAVCR2,1
GO:0003430,GO:0003430,growth plate cartilage chondrocyte growth,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,TGFBR2,1
GO:0015891,GO:0015891,siderophore transport,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,LCN2,1
GO:0045168,GO:0045168,cell-cell signaling involved in cell fate commitment,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,DLL1,1
GO:0046331,GO:0046331,lateral inhibition,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,DLL1,1
GO:0048320,GO:0048320,axial mesoderm formation,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,EPHA2,1
GO:0060400,GO:0060400,negative regulation of growth hormone receptor signaling pathway,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,GDF15,1
GO:0061110,GO:0061110,dense core granule biogenesis,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,CHGA,1
GO:0061713,GO:0061713,anterior neural tube closure,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,FOLR1,1
GO:0090716,GO:0090716,adaptive immune memory response,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,TNFRSF14,1
GO:1901491,GO:1901491,negative regulation of lymphangiogenesis,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,EPHA2,1
GO:1990428,GO:1990428,miRNA transport,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,TGFBR2,1
GO:1990523,GO:1990523,bone regeneration,1/36,3/18800,0.0057339918458937,0.027822482447214,0.0139126647568358,CCN3,1
GO:0001763,GO:0001763,morphogenesis of a branching structure,3/36,199/18800,0.0064513463481633,0.0305311192798503,0.0152671217601598,CSF1/EPHA2/TGFBR2,3
GO:0007179,GO:0007179,transforming growth factor beta receptor signaling pathway,3/36,200/18800,0.0065410498561298,0.0307708534390497,0.0153870011057226,FOLR1/GDF15/TGFBR2,3
GO:0009612,GO:0009612,response to mechanical stimulus,3/36,201/18800,0.0066314987011614,0.0310072802905823,0.015505226628234,LTBR/TGFBR2/TNFRSF1A,3
GO:0048645,GO:0048645,animal organ formation,2/36,65/18800,0.006874560635661,0.031854195377853,0.0159287275041554,FOLR1/TGFBR2,2
GO:1901215,GO:1901215,negative regulation of neuron death,3/36,209/18800,0.0073821103376567,0.0322015219024169,0.016102408537348,CHGA/CSF1/TNFRSF1B,3
GO:0002838,GO:0002838,negative regulation of immune response to tumor cell,1/36,4/18800,0.007638209343023,0.0322015219024169,0.016102408537348,HAVCR2,1
GO:0033366,GO:0033366,protein localization to secretory granule,1/36,4/18800,0.007638209343023,0.0322015219024169,0.016102408537348,CHGA,1
GO:0038098,GO:0038098,sequestering of BMP from receptor via BMP binding,1/36,4/18800,0.007638209343023,0.0322015219024169,0.016102408537348,NBL1,1
GO:0045608,GO:0045608,negative regulation of inner ear auditory receptor cell differentiation,1/36,4/18800,0.007638209343023,0.0322015219024169,0.016102408537348,DLL1,1
GO:0045632,GO:0045632,negative regulation of mechanoreceptor differentiation,1/36,4/18800,0.007638209343023,0.0322015219024169,0.016102408537348,DLL1,1
GO:0048319,GO:0048319,axial mesoderm morphogenesis,1/36,4/18800,0.007638209343023,0.0322015219024169,0.016102408537348,EPHA2,1
GO:0071603,GO:0071603,endothelial cell-cell adhesion,1/36,4/18800,0.007638209343023,0.0322015219024169,0.016102408537348,CCN3,1
GO:0150098,GO:0150098,glial cell-neuron signaling,1/36,4/18800,0.007638209343023,0.0322015219024169,0.016102408537348,TNFRSF1B,1
GO:1900738,GO:1900738,positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,1/36,4/18800,0.007638209343023,0.0322015219024169,0.016102408537348,CHGA,1
GO:1990086,GO:1990086,lens fiber cell apoptotic process,1/36,4/18800,0.007638209343023,0.0322015219024169,0.016102408537348,TGFBR2,1
GO:2000670,GO:2000670,positive regulation of dendritic cell apoptotic process,1/36,4/18800,0.007638209343023,0.0322015219024169,0.016102408537348,LGALS9,1
GO:2000981,GO:2000981,negative regulation of inner ear receptor cell differentiation,1/36,4/18800,0.007638209343023,0.0322015219024169,0.016102408537348,DLL1,1
GO:0071260,GO:0071260,cellular response to mechanical stimulus,2/36,70/18800,0.0079341070941177,0.0329981866475031,0.0165007816711258,LTBR/TNFRSF1A,2
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,2/36,72/18800,0.0083772585536882,0.0342867637887028,0.0171451361715859,HAVCR2/LGALS9,2
GO:0007596,GO:0007596,blood coagulation,3/36,221/18800,0.0085993446527665,0.0348407540310801,0.0174221596376039,CD59/PLAUR/THBD,3
GO:0150076,GO:0150076,neuroinflammatory response,2/36,73/18800,0.0086029340802602,0.0348407540310801,0.0174221596376039,IFNGR1/TNFRSF1B,2
GO:0050817,GO:0050817,coagulation,3/36,226/18800,0.0091393568505722,0.0358114194231809,0.0179075419976066,CD59/PLAUR/THBD,3
GO:0007599,GO:0007599,hemostasis,3/36,227/18800,0.0092496998928169,0.0358114194231809,0.0179075419976066,CD59/PLAUR/THBD,3
GO:0043299,GO:0043299,leukocyte degranulation,2/36,76/18800,0.0092962319164925,0.0358114194231809,0.0179075419976066,CHGA/LGALS9,2
GO:0055117,GO:0055117,regulation of cardiac muscle contraction,2/36,77/18800,0.009532719579277,0.0358114194231809,0.0179075419976066,CHGA/DSC2,2
GO:0001757,GO:0001757,somite specification,1/36,5/18800,0.0095388809999529,0.0358114194231809,0.0179075419976066,DLL1,1
GO:0007386,GO:0007386,compartment pattern specification,1/36,5/18800,0.0095388809999529,0.0358114194231809,0.0179075419976066,DLL1,1
GO:0035634,GO:0035634,response to stilbenoid,1/36,5/18800,0.0095388809999529,0.0358114194231809,0.0179075419976066,LY6D,1
GO:0048633,GO:0048633,positive regulation of skeletal muscle tissue growth,1/36,5/18800,0.0095388809999529,0.0358114194231809,0.0179075419976066,DLL1,1
GO:1902731,GO:1902731,negative regulation of chondrocyte proliferation,1/36,5/18800,0.0095388809999529,0.0358114194231809,0.0179075419976066,CCN3,1
GO:1904447,GO:1904447,folate import across plasma membrane,1/36,5/18800,0.0095388809999529,0.0358114194231809,0.0179075419976066,FOLR1,1
GO:1905007,GO:1905007,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,1/36,5/18800,0.0095388809999529,0.0358114194231809,0.0179075419976066,TGFBR2,1
GO:0032418,GO:0032418,lysosome localization,2/36,79/18800,0.0100137141196932,0.0370531436131572,0.0185284676252306,CHGA/LGALS9,2
GO:1990849,GO:1990849,vacuolar localization,2/36,79/18800,0.0100137141196932,0.0370531436131572,0.0185284676252306,CHGA/LGALS9,2
GO:0031667,GO:0031667,response to nutrient levels,4/36,446/18800,0.0101033710897156,0.0372954583527063,0.0186496373930032,DSC2/FOLR1/GDF15/TGFBR2,4
GO:0001570,GO:0001570,vasculogenesis,2/36,80/18800,0.0102581999770241,0.0376703200824065,0.0188370874375987,EPHA2/TGFBR2,2
GO:0003012,GO:0003012,muscle system process,4/36,449/18800,0.0103369005538811,0.037795823589191,0.0188998456123594,CHGA/DSC2/TNFRSF1A/TNFRSF1B,4
GO:0019318,GO:0019318,hexose metabolic process,3/36,242/18800,0.0109994451935536,0.0390670552012514,0.0195355264607683,B4GALT1/IGFBP4/TFF3,3
GO:0048762,GO:0048762,mesenchymal cell differentiation,3/36,244/18800,0.0112462562103127,0.0390670552012514,0.0195355264607683,EFNA1/FOLR1/TGFBR2,3
GO:0045926,GO:0045926,negative regulation of growth,3/36,245/18800,0.0113708630277002,0.0390670552012514,0.0195355264607683,CCN3/GDF15/TGFBR2,3
GO:0002023,GO:0002023,reduction of food intake in response to dietary excess,1/36,6/18800,0.0114360132310785,0.0390670552012514,0.0195355264607683,GDF15,1
GO:0043415,GO:0043415,positive regulation of skeletal muscle tissue regeneration,1/36,6/18800,0.0114360132310785,0.0390670552012514,0.0195355264607683,TGFBR2,1
GO:0070309,GO:0070309,lens fiber cell morphogenesis,1/36,6/18800,0.0114360132310785,0.0390670552012514,0.0195355264607683,EPHA2,1
GO:0072014,GO:0072014,proximal tubule development,1/36,6/18800,0.0114360132310785,0.0390670552012514,0.0195355264607683,DLL1,1
GO:0086073,GO:0086073,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,1/36,6/18800,0.0114360132310785,0.0390670552012514,0.0195355264607683,DSC2,1
GO:1900425,GO:1900425,negative regulation of defense response to bacterium,1/36,6/18800,0.0114360132310785,0.0390670552012514,0.0195355264607683,HAVCR2,1
GO:1903969,GO:1903969,regulation of response to macrophage colony-stimulating factor,1/36,6/18800,0.0114360132310785,0.0390670552012514,0.0195355264607683,CSF1,1
GO:0006898,GO:0006898,receptor-mediated endocytosis,3/36,246/18800,0.0114962719788564,0.0390670552012514,0.0195355264607683,DLL1/FOLR1/TGFBR2,3
GO:0034612,GO:0034612,response to tumor necrosis factor,3/36,249/18800,0.01187732085496,0.0401901449105334,0.0200971287781294,TNFRSF14/TNFRSF1A/TNFRSF1B,3
GO:0002088,GO:0002088,lens development in camera-type eye,2/36,87/18800,0.012043080950922,0.0405730871337832,0.0202886194829369,EPHA2/TGFBR2,2
GO:0045927,GO:0045927,positive regulation of growth,3/36,256/18800,0.0127946765092761,0.0426940961735872,0.021349232523955,CSF1/DLL1/TGFBR2,3
GO:0071559,GO:0071559,response to transforming growth factor beta,3/36,258/18800,0.0130640704370765,0.0426940961735872,0.021349232523955,FOLR1/GDF15/TGFBR2,3
GO:0043305,GO:0043305,negative regulation of mast cell degranulation,1/36,7/18800,0.0133296124395319,0.0426940961735872,0.021349232523955,LGALS9,1
GO:0048631,GO:0048631,regulation of skeletal muscle tissue growth,1/36,7/18800,0.0133296124395319,0.0426940961735872,0.021349232523955,DLL1,1
GO:0060462,GO:0060462,lung lobe development,1/36,7/18800,0.0133296124395319,0.0426940961735872,0.021349232523955,TGFBR2,1
GO:0060463,GO:0060463,lung lobe morphogenesis,1/36,7/18800,0.0133296124395319,0.0426940961735872,0.021349232523955,TGFBR2,1
GO:0061002,GO:0061002,negative regulation of dendritic spine morphogenesis,1/36,7/18800,0.0133296124395319,0.0426940961735872,0.021349232523955,EFNA1,1
GO:0061518,GO:0061518,microglial cell proliferation,1/36,7/18800,0.0133296124395319,0.0426940961735872,0.021349232523955,CSF1,1
GO:0070244,GO:0070244,negative regulation of thymocyte apoptotic process,1/36,7/18800,0.0133296124395319,0.0426940961735872,0.021349232523955,EFNA1,1
GO:0086042,GO:0086042,cardiac muscle cell-cardiac muscle cell adhesion,1/36,7/18800,0.0133296124395319,0.0426940961735872,0.021349232523955,DSC2,1
GO:0097577,GO:0097577,sequestering of iron ion,1/36,7/18800,0.0133296124395319,0.0426940961735872,0.021349232523955,LCN2,1
GO:1902961,GO:1902961,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,1/36,7/18800,0.0133296124395319,0.0426940961735872,0.021349232523955,EFNA1,1
GO:1903348,GO:1903348,positive regulation of bicellular tight junction assembly,1/36,7/18800,0.0133296124395319,0.0426940961735872,0.021349232523955,EPHA2,1
GO:2001268,GO:2001268,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,1/36,7/18800,0.0133296124395319,0.0426940961735872,0.021349232523955,PLAUR,1
GO:0061448,GO:0061448,connective tissue development,3/36,260/18800,0.0133367170159877,0.0426940961735872,0.021349232523955,CCN3/CSF1/TGFBR2,3
GO:0002718,GO:0002718,regulation of cytokine production involved in immune response,2/36,98/18800,0.0151012498281261,0.0457777270595416,0.0228912057404536,TNFRSF14/TNFRSF1B,2
GO:0003149,GO:0003149,membranous septum morphogenesis,1/36,8/18800,0.0152196850172034,0.0457777270595416,0.0228912057404536,TGFBR2,1
GO:0007341,GO:0007341,penetration of zona pellucida,1/36,8/18800,0.0152196850172034,0.0457777270595416,0.0228912057404536,B4GALT1,1
GO:0045136,GO:0045136,development of secondary sexual characteristics,1/36,8/18800,0.0152196850172034,0.0457777270595416,0.0228912057404536,B4GALT1,1
GO:0048318,GO:0048318,axial mesoderm development,1/36,8/18800,0.0152196850172034,0.0457777270595416,0.0228912057404536,EPHA2,1
GO:0071694,GO:0071694,maintenance of protein location in extracellular region,1/36,8/18800,0.0152196850172034,0.0457777270595416,0.0228912057404536,NBL1,1
GO:0002367,GO:0002367,cytokine production involved in immune response,2/36,100/18800,0.0156896708476182,0.0470080817822814,0.0235064460527423,TNFRSF14/TNFRSF1B,2
GO:0098742,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,3/36,279/18800,0.0160901512463712,0.048021476543812,0.0240131952837018,DSC2/NECTIN4/TGFBR2,3
GO:0051146,GO:0051146,striated muscle cell differentiation,3/36,281/18800,0.0163972747250929,0.0486557594246507,0.0243303691771116,CCN3/DLL1/GDF15,3
GO:0048872,GO:0048872,homeostasis of number of cells,3/36,282/18800,0.0165520773530907,0.0487891390442872,0.0243970658112785,CCN3/CSF1/LGALS9,3
GO:0002315,GO:0002315,marginal zone B cell differentiation,1/36,9/18800,0.0171062373447566,0.0487891390442872,0.0243970658112785,DLL1,1
GO:0034351,GO:0034351,negative regulation of glial cell apoptotic process,1/36,9/18800,0.0171062373447566,0.0487891390442872,0.0243970658112785,DLL1,1
GO:0051593,GO:0051593,response to folic acid,1/36,9/18800,0.0171062373447566,0.0487891390442872,0.0243970658112785,FOLR1,1
GO:0060054,GO:0060054,positive regulation of epithelial cell proliferation involved in wound healing,1/36,9/18800,0.0171062373447566,0.0487891390442872,0.0243970658112785,B4GALT1,1
GO:1904238,GO:1904238,pericyte cell differentiation,1/36,9/18800,0.0171062373447566,0.0487891390442872,0.0243970658112785,EPHA2,1
GO:0042886,GO:0042886,amide transport,3/36,287/18800,0.0173385180402733,0.049269490490132,0.024637266111312,CCN3/CHGA/FOLR1,3
